Isolation of GD3 synthase gene by expression cloning of GM3 alpha-2,8-sialyltransferase cDNA using anti-GD2 monoclonal antibody
about
Expression cloning and functional characterization of human cDNA for ganglioside GM3 synthaseExpression cloning of mouse cDNA of CMP-NeuAc:Lactosylceramide alpha2,3-sialyltransferase, an enzyme that initiates the synthesis of gangliosidesMolecular cloning of a novel alpha2,3-sialyltransferase (ST3Gal VI) that sialylates type II lactosamine structures on glycoproteins and glycolipidsMolecular cloning and functional expression of two members of mouse NeuAcalpha2,3Galbeta1,3GalNAc GalNAcalpha2,6-sialyltransferase family, ST6GalNAc III and IVDifferential biosynthesis of polysialic acid on neural cell adhesion molecule (NCAM) and oligosaccharide acceptors by three distinct alpha 2,8-sialyltransferases, ST8Sia IV (PST), ST8Sia II (STX), and ST8Sia IIIIdentification and characterization of three novel beta 1,3-N-acetylglucosaminyltransferases structurally related to the beta 1,3-galactosyltransferase familyA human STX cDNA confers polysialic acid expression in mammalian cellsGenomic organization and chromosomal mapping of the Gal beta 1,3GalNAc/Gal beta 1,4GlcNAc alpha 2,3-sialyltransferaseT cell homeostatic proliferation elicits effective antitumor autoimmunityRole of Cytokine-Induced Glycosylation Changes in Regulating Cell Interactions and Cell Signaling in Inflammatory Diseases and CancerIsolation of 10 differentially expressed cDNAs in differentiated Neuro2a cells induced through controlled expression of the GD3 synthase geneTriptolide downregulates human GD3 synthase (hST8Sia I) gene expression in SK-MEL-2 human melanoma cellsMolecular cloning of brain-specific GD1alpha synthase (ST6GalNAc V) containing CAG/Glutamine repeatsMolecular cloning of a developmentally regulated N-acetylgalactosamine alpha2,6-sialyltransferase specific for sialylated glycoconjugatesMolecular cloning and expression of a fifth type of alpha2,8-sialyltransferase (ST8Sia V). Its substrate specificity is similar to that of SAT-V/III, which synthesize GD1c, GT1a, GQ1b and GT39-O-Acetylation of sialic acids is catalysed by CASD1 via a covalent acetyl-enzyme intermediateSerologic responses in patients with malignant mesothelioma: evidence for both public and private specificities.Peptides mimicking GD2 ganglioside elicit cellular, humoral and tumor-protective immune responses in miceImpaired hypoglossal nerve regeneration in mutant mice lacking complex gangliosides: down-regulation of neurotrophic factors and receptors as possible mechanisms.Evolutionary history of the alpha2,8-sialyltransferase (ST8Sia) gene family: tandem duplications in early deuterostomes explain most of the diversity found in the vertebrate ST8Sia genes.Ganglioside GD3 promotes cell growth and invasion through p130Cas and paxillin in malignant melanoma cells.Targeting of a developmentally regulated epitope of CD43 for the treatment of acute leukemia.Melanoma immunotherapy by targeted IL-2 depends on CD4(+) T-cell help mediated by CD40/CD40L interaction.TEGS-CN: A Statistical Method for Pathway Analysis of Genome-wide Copy Number ProfileFundamental study of small interfering RNAs for ganglioside GD3 synthase gene as a therapeutic target of lung cancers.Functional activation of Src family kinase yes protein is essential for the enhanced malignant properties of human melanoma cells expressing ganglioside GD3.Activation of preexisting T cell clones by targeted interleukin 2 therapy.Molecular cloning and genomic analysis of mouse Galbeta1, 3GalNAc-specific GalNAc alpha2,6-sialyltransferase.Potential of the trifunctional bispecific antibody surek depends on dendritic cells: rationale for a new approach of tumor immunotherapy.Expression cloning of rat cDNA encoding UDP-galactose:GD2 beta1,3-galactosyltransferase that determines the expression of GD1b/GM1/GA1.In Situ Tumor Vaccination by Combining Local Radiation and Tumor-Specific Antibody or Immunocytokine Treatments.Cloning and transcriptional regulation of genes responsible for synthesis of gangliosides.Long-lived and transferable tumor immunity in mice after targeted interleukin-2 therapy.An antibody-interleukin 2 fusion protein overcomes tumor heterogeneity by induction of a cellular immune response.Potent CD4+ T cell-associated antitumor memory responses induced by trifunctional bispecific antibodies in combination with immune checkpoint inhibition.How Do Gangliosides Regulate RTKs Signaling?The sialyltransferase "sialylmotif" participates in binding the donor substrate CMP-NeuAc.Mutation of the sialyltransferase S-sialylmotif alters the kinetics of the donor and acceptor substrates.Ganglioside GD3 induces convergence and synergism of adhesion and hepatocyte growth factor/Met signals in melanomas.Membrane sialidase NEU3 is highly expressed in human melanoma cells promoting cell growth with minimal changes in the composition of gangliosides.
P2860
Q22008027-D8D0EA9C-3D33-4890-BA10-56812F8D3BB0Q22009092-E67F5671-6880-4592-BFE4-FEE495768116Q22009402-10BFA5D4-7EDF-4D46-BD09-5381AEC16CD3Q22009412-5DA59817-9790-4CC1-B5EA-8DBC6D862C64Q22253906-CE0527B0-DD3B-44DB-8436-6B0AD9686E6CQ24290427-FB2150FB-D9B0-4C82-AFD3-D734F7B899FEQ24310385-545C1C5B-C45B-4786-A1CA-D1742DC54556Q24316400-793D15B0-584C-4D83-A858-AD5050D5357AQ24553060-05E40DBA-CE0D-47F9-8846-F1F243D002B0Q28077907-7D2D883A-6FF2-455E-A4D3-F84128885645Q28142379-E76F6A7E-2BD9-4CC0-9196-3E7E5381CDB7Q28385576-EFEE9676-27D2-49FC-AA8E-65F76774C556Q28508776-3EDD0A05-7EC7-4D78-AE65-D703371441C3Q28569588-77D4881A-56C7-4C5B-84A2-59366CA07F9AQ28591045-FBF2AB67-0645-49D1-A56E-859D8D221036Q29871471-9DC11D02-3388-4B37-8D30-1E2E88F38933Q30863574-CCAE137F-AF22-4A1F-9012-AE9DD8A2D964Q33312280-337C9E06-2541-4FE4-A939-2E7FC43AC2A1Q33334765-6561004F-9D25-4C8C-8BD0-76F9DA6A529EQ33371356-DBF888D3-BEBD-4E0F-8041-AB2D38A6FC39Q33904439-5A605783-F626-470E-B578-25E3E3EDA8BFQ33944427-8F9237D3-EB4F-4ABC-A43C-9DFF6D31DA8BQ34433429-116B3297-35C0-40B7-B2EC-13C40F7A0C38Q34444842-54D36876-45C4-426C-BC7C-441A0D47F290Q34550428-70E424CF-4E37-4CEE-A5DB-66883CBE95B5Q34998047-6494768B-5734-4B83-9AED-2C9993D4BF51Q36219989-3C038989-960D-4109-A4AC-63504A34B7F7Q36802909-ECAE691A-3F36-4A65-B5DD-A17C8C28C1DCQ36821533-EFD3216E-9781-4FCC-A93F-68991D8E279EQ36884478-CD356732-9751-48D0-8A77-05D2E766301CQ37059790-BB1B3C62-0410-40E6-A334-47A4B00E5BBCQ37130704-F9BCA10A-ACCC-4BA3-A3FB-9EFFB286D446Q37362175-E87835C4-3ECE-4EDD-8459-44C7DA24736FQ37443542-51A4A3B3-F9F7-4EDC-889F-FFE9422B90C8Q37706213-B0557322-0BC6-4634-9E32-C9A90ACFB59EQ38202831-2332DFA2-1EE2-4BB0-8D0E-51CC1FFB9031Q38299599-D3DEEDED-7CE7-46EA-9435-23D3EA23B557Q38337475-756C93CC-2D03-4070-BB1E-256D45039EC6Q39039136-FB110938-CB0B-4547-AD9C-39B7DE573163Q39479013-562F8FEE-1526-46BC-8AF0-49B6BE500650
P2860
Isolation of GD3 synthase gene by expression cloning of GM3 alpha-2,8-sialyltransferase cDNA using anti-GD2 monoclonal antibody
description
1994 nî lūn-bûn
@nan
1994 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Isolation of GD3 synthase gene ...... g anti-GD2 monoclonal antibody
@ast
Isolation of GD3 synthase gene ...... g anti-GD2 monoclonal antibody
@en
Isolation of GD3 synthase gene ...... g anti-GD2 monoclonal antibody
@nl
type
label
Isolation of GD3 synthase gene ...... g anti-GD2 monoclonal antibody
@ast
Isolation of GD3 synthase gene ...... g anti-GD2 monoclonal antibody
@en
Isolation of GD3 synthase gene ...... g anti-GD2 monoclonal antibody
@nl
prefLabel
Isolation of GD3 synthase gene ...... g anti-GD2 monoclonal antibody
@ast
Isolation of GD3 synthase gene ...... g anti-GD2 monoclonal antibody
@en
Isolation of GD3 synthase gene ...... g anti-GD2 monoclonal antibody
@nl
P2093
P2860
P356
P1476
Isolation of GD3 synthase gene ...... g anti-GD2 monoclonal antibody
@en
P2093
A Yamamoto
K Furukawa
K Takamiya
M Haraguchi
S Yamashiro
P2860
P304
P356
10.1073/PNAS.91.22.10455
P407
P577
1994-10-25T00:00:00Z